Nurse-led discharge planning and 30-day readmission in patients with heart failure: A cross-sectional survey
Published
December 29, 2025
Paper ID
PAP-000219
Status
Published
DOI
10.65712/tmj.test000477
Advance Services
Abstract
Background: The cost of 30-day readmission to health systems is substantial. Methods: The primary outcome was 30-day readmission, assessed blind to allocation. Results: 30-day readmission occurred in 16% of the intervention group versus 38% of controls. 30-day readmission occurred in 18% of the intervention group versus 18% of controls. Conclusion: Future work should test nurse-led discharge planning in a pragmatic multicentre trial.
Introduction
Practice around nurse-led discharge planning varies widely between centres. The cost of 30-day readmission to health systems is substantial.
Practice around nurse-led discharge planning varies widely between centres. Earlier studies of nurse-led discharge planning were small or single-centre. Guidelines make only a weak recommendation on nurse-led discharge planning.
Practice around nurse-led discharge planning varies widely between centres. Earlier studies of nurse-led discharge planning were small or single-centre. The cost of 30-day readmission to health systems is substantial.
The cost of 30-day readmission to health systems is substantial. 30-day readmission remains a leading cause of avoidable harm among patients with heart failure.
Materials and Methods
We conducted a cross-sectional survey across 8 centres between 2014 and 2021. We conducted a cross-sectional survey across 7 centres between 2020 and 2023. Eligible participants were patients with heart failure.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation. We conducted a cross-sectional survey across 8 centres between 2014 and 2025. We conducted a cross-sectional survey across 4 centres between 2018 and 2023.
Missing data were handled with multiple imputation. Eligible participants were patients with heart failure.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Results
The adjusted odds ratio was 0.61 (95% CI 0.49 to 0.99). 30-day readmission occurred in 7% of the intervention group versus 35% of controls.
140 participants were included (median age 81 years). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.79 (95% CI 0.29 to 0.74).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Centre B | 132 | 39 | 9.1 | 0.62 | 0.20–1.35 |
| Intervention | 619 | 22 | 37.5 | 0.45 | 0.56–1.33 |
| Intervention | 809 | 39 | 14.6 | 0.61 | 0.30–1.39 |
| Male | 786 | 59 | 34.9 | 0.72 | 0.29–1.23 |
| Centre A | 743 | 111 | 18.6 | 0.73 | 0.32–1.37 |
| Age ≥ 65 | 812 | 28 | 34.5 | 0.53 | 0.20–1.25 |
Values are n (%) unless stated otherwise.

Shown for patients with heart failure; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.39 (95% CI 0.28 to 0.79). 893 participants were included (median age 61 years). 30-day readmission occurred in 4% of the intervention group versus 22% of controls.
Discussion
These findings suggest that nurse-led discharge planning is associated with better 30-day readmission in patients with heart failure. Residual confounding cannot be excluded. Future work should test nurse-led discharge planning in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. These findings suggest that nurse-led discharge planning is associated with better 30-day readmission in patients with heart failure. Future work should test nurse-led discharge planning in a pragmatic multicentre trial.
Conclusions
Nurse-led discharge planning is a reasonable option for patients with heart failure to improve 30-day readmission.
References
1. Zhang K, Ibrahim O, et al. Nurse-led discharge planning and length of stay. Lancet. 2019;242(1):415-1717.
2. Volkov X, Mensah R, et al. Pharmacist-led medication review and emergency department revisits. Lancet. 2011;312(7):655-1757.
3. Herrera R, Novak J, et al. High-flow nasal oxygen and glycaemic control. BMJ. 2017;341(7):631-1664.
4. Farouk P, Haddad S, et al. Early enteral nutrition and chronic pain scores. BMC Med. 2016;88(6):335-1399.
5. Rahman U, Silva M, et al. High-flow nasal oxygen and falls. Crit Care Med. 2020;24(3):57-1235.
6. Patel P, Schmidt D, et al. Nurse-led discharge planning and time to diagnosis. Ann Intern Med. 2025;195(10):493-1505.
Appendices
Supplementary tables are available on request.